Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 10894863

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2000 Jul
First author
Vanhoefer U

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2000 Jul;18(14):2645-7. doi: 10.1200/JCO.2000.18.14.2645.
    note
    Source null
    related pmid
    10894862
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2000 Nov 15;18(22):3874-5. doi: 10.1200/JCO.2000.18.22.3874.
    note
    Source null
    related pmid
    11078502
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2000 Dec 1;18(23):4001-3. doi: 10.1200/JCO.2000.18.23.4001.
    note
    Source null
    related pmid
    11099333
    relationship
    Comment in

Authors and identifiers

  1. name
    Vanhoefer U
    type
    Author
  2. name
    Rougier P
    type
    Author
  3. name
    Wilke H
    type
    Author
  4. name
    Ducreux MP
    type
    Author
  5. name
    Lacave AJ
    type
    Author
  6. name
    Van Cutsem E
    type
    Author
  7. name
    Planker M
    type
    Author
  8. name
    Santos JG
    type
    Author
  9. name
    Piedbois P
    type
    Author
  10. name
    Paillot B
    type
    Author
  11. name
    Bodenstein H
    type
    Author
  12. name
    Schmoll HJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Vanhoefer U
    type
    Author
  2. name
    Rougier P
    type
    Author
  3. name
    Wilke H
    type
    Author
  4. name
    Ducreux MP
    type
    Author
  5. name
    Lacave AJ
    type
    Author
  6. name
    Van Cutsem E
    type
    Author
  7. name
    Planker M
    type
    Author
  8. name
    Santos JG
    type
    Author
  9. name
    Piedbois P
    type
    Author
  10. name
    Paillot B
    type
    Author
  11. name
    Bodenstein H
    type
    Author
  12. name
    Schmoll HJ
    type
    Author
bibliography ids
  1. nci-bib-39d5144042375b376d81931c
book metadata
content sha256
bf31a58453aa6beeee7a33a3327c56d46ddd2db096c363f4d20be186283413d2
document type
citation
dois
  1. 10.1200/JCO.2000.18.14.2648
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:10894863
immutable id
pubmed:10894863@bf31a58453aa6beeee7a33a3327c56d46ddd2db096c363f4d20be186283413d2
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
14
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2648-57
volume
18
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2000 Jul;18(14):2645-7. doi: 10.1200/JCO.2000.18.14.2645.
    note
    Source null
    related pmid
    10894862
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2000 Nov 15;18(22):3874-5. doi: 10.1200/JCO.2000.18.22.3874.
    note
    Source null
    related pmid
    11078502
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2000 Dec 1;18(23):4001-3. doi: 10.1200/JCO.2000.18.23.4001.
    note
    Source null
    related pmid
    11099333
    relationship
    Comment in
outcomes validated
false
pmid
10894863
provenance
batch id
c98b220a79580c9840c7
provider
NCBI PubMed ESummary
record sha256
f53434c3d47759e86979696992feabd7c7e00b76243a0acd9fe6b6f8ef6bfcaf
response sha256
d5d875b1aa149faaecebc150cec3cacc2861402b103226e5006d2b0ce5dccd23
retrieved at
2026-09-09T23:45:37.924736+00:00
publication date
display
2000 Jul
precision
month
year
2000
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase III
  3. Comparative Study
  4. Journal Article
  5. Multicenter Study
  6. Randomized Controlled Trial
  7. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/10894863/
title
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.

Preserved source evidence · Not medical advice